全文获取类型
收费全文 | 2761篇 |
免费 | 147篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 56篇 |
妇产科学 | 33篇 |
基础医学 | 390篇 |
口腔科学 | 103篇 |
临床医学 | 183篇 |
内科学 | 786篇 |
皮肤病学 | 50篇 |
神经病学 | 313篇 |
特种医学 | 108篇 |
外科学 | 321篇 |
综合类 | 4篇 |
一般理论 | 1篇 |
预防医学 | 73篇 |
眼科学 | 42篇 |
药学 | 194篇 |
中国医学 | 4篇 |
肿瘤学 | 238篇 |
出版年
2023年 | 19篇 |
2022年 | 34篇 |
2021年 | 88篇 |
2020年 | 53篇 |
2019年 | 65篇 |
2018年 | 70篇 |
2017年 | 63篇 |
2016年 | 63篇 |
2015年 | 59篇 |
2014年 | 83篇 |
2013年 | 94篇 |
2012年 | 173篇 |
2011年 | 185篇 |
2010年 | 109篇 |
2009年 | 85篇 |
2008年 | 138篇 |
2007年 | 149篇 |
2006年 | 108篇 |
2005年 | 109篇 |
2004年 | 115篇 |
2003年 | 106篇 |
2002年 | 93篇 |
2001年 | 88篇 |
2000年 | 95篇 |
1999年 | 76篇 |
1998年 | 19篇 |
1997年 | 19篇 |
1996年 | 25篇 |
1995年 | 17篇 |
1994年 | 8篇 |
1993年 | 18篇 |
1992年 | 58篇 |
1991年 | 45篇 |
1990年 | 41篇 |
1989年 | 32篇 |
1988年 | 26篇 |
1987年 | 42篇 |
1986年 | 24篇 |
1985年 | 38篇 |
1984年 | 29篇 |
1983年 | 25篇 |
1982年 | 15篇 |
1981年 | 16篇 |
1980年 | 9篇 |
1979年 | 18篇 |
1978年 | 9篇 |
1975年 | 7篇 |
1972年 | 11篇 |
1970年 | 8篇 |
1969年 | 7篇 |
排序方式: 共有2923条查询结果,搜索用时 31 毫秒
91.
92.
Taguchi Kumiko Bessho Nanami Hida Mari Narimatsu Haruka Matsumoto Takayuki Kobayashi Tsuneo 《Naunyn-Schmiedeberg's archives of pharmacology》2018,391(10):1075-1083
Naunyn-Schmiedeberg's Archives of Pharmacology - Abnormal G protein-coupled receptor kinase 2 (GRK2) accumulation has a crucial role in the development of insulin resistance and diabetes.... 相似文献
93.
Nami Ogawa Takashi Mori Ichiro Fujishima Hidetaka Wakabayashi Masataka Itoda Kenjiro Kunieda Takashi Shigematsu Shinta Nishioka Haruka Tohara Minoru Yamada Sumito Ogawa 《Journal of the American Medical Directors Association》2018,19(6):516-522
Background
Sarcopenic dysphagia is characterized by difficulty swallowing due to a loss of whole-body skeletal and swallowing muscle mass and function. However, no study has reported on swallowing muscle mass and quality in patients with sarcopenic dysphagia.Objective
To compare the differences in swallowing muscle mass and quality between sarcopenic and nonsarcopenic dysphagia.Method
A cross-sectional study was performed in 55 older patients, who had been recommended to undergo dysphagia assessment and/or rehabilitation. Sarcopenic dysphagia was diagnosed using a diagnostic algorithm for sarcopenic dysphagia. The thickness and area of tongue muscle and geniohyoid muscle (coronal plane and sagittal plane), and the echo-intensity of the tongue and geniohyoid muscles were examined by ultrasound.Results
The study participants included 31 males and 24 females (mean age of 82 ± 7 years), with 14 having possible sarcopenic dysphagia, 22 probable sarcopenic dysphagia, and 19 without sarcopenic dysphagia. The group with sarcopenic dysphagia had a significantly lower cross-sectional area and area of brightness of the tongue muscle than that observed in the group without sarcopenic dysphagia. The most specific factor for identifying the presence of sarcopenic dysphagia was tongue muscle area (sensitivity, 0.389; specificity, 0.947; cut-off value, 1536.0), while the factor with the highest sensitivity was geniohyoid muscle area brightness in sagittal sections (sensitivity, 0.806; specificity, 0.632; cut-off value, 20.1). Multivariate logistic regression analysis showed that the area of the tongue muscle and its area of brightness were independent risk factors for sarcopenic dysphagia. However, geniohyoid sagittal muscle area and area of brightness showed no significant independent association with sarcopenic dysphagia.Conclusion
Tongue muscle mass in patients with sarcopenic dysphagia was smaller than that in patients without the condition. Sarcopenic dysphagia was also associated with increased intensity of the tongue muscle. 相似文献94.
95.
96.
Ryuichi Tsujita Maho Tsubota Yusuke Hayashi Haruka Saeki Fumiko Sekiguchi Atsufumi Kawabata 《Journal of neuroimmune pharmacology》2018,13(2):179-188
High mobility group box 1 (HMGB1), a nuclear protein, once released into the extracellular space under pathological conditions, plays a pronociceptive role in redox-dependent distinct active forms, all-thiol HMGB1 (at-HMGB1) and disulfide HMGB1 (ds-HMGB1), that accelerate nociception through the receptor for advanced glycation endproducts (RAGE) and Toll-like receptor 4 (TLR4), respectively. Thrombomodulin (TM), an endothelial membrane protein, and soluble TM, known as TMα, promote thrombin-mediated activation of protein C and also sequester HMGB1, which might facilitate thrombin degradation of HMGB1. The present study aimed at clarifying the role of thrombin in TMα-induced suppression of peripheral HMGB1-dependent allodynia in mice. Thrombin-induced degradation of at-HMGB1 and ds-HMGB1 was accelerated by TMα in vitro. Intraplantar (i.pl.) injection of bovine thymus-derived HMGB1 in an unknown redox state, at-HMGB1, ds-HMGB1 or lipopolysaccharide (LPS), known to cause HMGB1 secretion, produced long-lasting mechanical allodynia in mice, as assessed by von Frey test. TMα, when preadministered i.pl., prevented the allodynia caused by bovine thymus-derived HMGB1, at-HMGB1, ds-HMGB1 or LPS, in a dose-dependent manner. The TMα-induced suppression of the allodynia following i.pl. at-HMGB1, ds-HMGB1 or LPS was abolished by systemic preadministration of argatroban, a thrombin-inhibiting agent, and accelerated by i.pl. co-administered thrombin. Our data clearly indicate that TMα is capable of promoting the thrombin-induced degradation of both at-HMGB1 and ds-HMGB1, and suppresses the allodynia caused by either HMGB1 in a thrombin-dependent manner. Considering the emerging role of HMGB1 in distinct pathological pain models, the present study suggests the therapeutic usefulness of TMα for treatment of intractable and/or persistent pain. 相似文献
97.
Future therapy of diabetes mellitus 总被引:2,自引:0,他引:2
For reaching near normal glycemic control, multiple daily insulin injections are necessary, although subcutaneous insulin therapy cannot get the physiological profile, results in hypoglycemia, weight gain, peripheral hyperinsulinemia, and may not be accepted for painful injections. Glucagon-like peptide 1(GLP-1) analogs and alternative routes of insulin, especially oral (enteric-gastrointestinal, inhaled) route, are most promising and attractive now. Biotechnology and biochemistry will make it possible to overcome several disadvantages of low absorption, short half-life, low bioavailability, and many clinical trials are now in progress. We will show the review of these drugs and another candidate for the treatment of diabetic complications, protein kinase C inhibitor. 相似文献
98.
Wakasa Haruka Tsugami Yusaku Koyama Taku Han Liang Nishimura Takanori Isobe Naoki Kobayashi Ken 《Journal of mammary gland biology and neoplasia》2022,27(2):155-170
Journal of Mammary Gland Biology and Neoplasia - In the mammary glands during pregnancy, the alveolar buds are first branched from the mammary ducts after which they form the alveolar luminal... 相似文献
99.
100.
Ryuichiro Sato Masaya Oikawa Tetsuya Kakita Takaho Okada Tomoya Abe Takashi Yazawa Haruyuki Tsuchiya Naoya Akazawa Masaki Sato Tetsuya Ohira Yoshihiro Harada Haruka Okano Kei Ito Noriaki Ohuchi Takashi Tsuchiya 《Surgery today》2020,50(3):232-239
Inflammation-based markers predict the long-term outcomes of various malignancies. We investigated the relationship between the modified Glasgow prognostic score (mGPS) and the long-term outcomes of obstructive colorectal cancer in patients who underwent self-expandable metallic colonic stent placement and subsequently received curative surgery. We retrospectively analyzed 63 consecutive patients with pathological stage II and III obstructive colorectal cancer from 2013 to 2018. The mGPS was calculated before stenting and surgery, and the difference of the scores was defined as the d-mGPS. All d-mGPS = 2 patients were > 70 years of age (p = 0.01). Postoperative complications were more common in the preoperative mGPS = 2 group (p = 0.02). The postoperative hospital stay was significantly longer in the mGPS = 2 group (p = 0.007). Multivariate analyses revealed that d-mGPS was an independent prognostic factor for overall survival (OS) (hazard ratio [HR] = 9.18, p = 0.004) and cancer-specific survival (HR = 9.98, p = 0.01). Preoperative mGPS = 2 was significantly associated with poor OS (HR = 5.53, p = 0.04). The results indicated that mGPS might serve as a valuable indicator of the immunonutritional status of preoperative patients, and a preoperative change of the status might affect the long-term outcomes of patients with obstructive colorectal cancer. 相似文献